Factor structure of cognition and functional capacity in two studies of schizophrenia and bipolar disorder: Implications for genomic studies. PD Harvey, M Aslan, M Du, H Zhao, LJ Siever, A Pulver, JM Gaziano, ... Neuropsychology 30 (1), 28, 2016 | 45 | 2016 |
Biomarker signatures of sickle cell disease severity M Du, S Van Ness, V Gordeuk, SM Nouraie, S Nekhai, M Gladwin, ... Blood Cells, Molecules, and Diseases 72, 1-9, 2018 | 36 | 2018 |
Patterns of multi-domain cognitive aging in participants of the Long Life Family Study P Sebastiani, SL Andersen, B Sweigart, M Du, S Cosentino, ... Geroscience 42, 1335-1350, 2020 | 29 | 2020 |
Consistency of recall for deployment-related traumatic brain injury ML Alosco, M Aslan, M Du, J Ko, L Grande, SP Proctor, J Concato, ... The Journal of Head Trauma Rehabilitation 31 (5), 360-368, 2016 | 24 | 2016 |
Digitally generated trail making test data: analysis using hidden Markov modeling M Du, SL Andersen, S Cosentino, RM Boudreau, TT Perls, P Sebastiani Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14 (1 …, 2022 | 11 | 2022 |
Association between apoe alleles and change of neuropsychological tests in the long life family study M Du, SL Andersen, N Schupf, MF Feitosa, MS Barker, TT Perls, ... Journal of Alzheimer's Disease 79 (1), 117-125, 2021 | 7 | 2021 |
Slower decline in processing speed is associated with familial longevity SL Andersen, M Du, S Cosentino, N Schupf, AL Rosso, TT Perls, ... Gerontology 68 (1), 17-29, 2022 | 6 | 2022 |
Systematic Literature Review of Key Outcomes Used to Assess Adjunctive Treatments for Parkinson’s Disease RW A. Thach, M. Zichlin, M. Peddle, M. Du, A. Lerner, N. Kirson, A. Bowling ... Movement Disorders 37 (suppl 2), 2022 | 3 | 2022 |
EE121 Numbers Needed to Treat and Costs per Improved Outcome Among Treatments for Myasthenia Gravis C Qi, J Wang, H Yang, D Gelinas, E Brauer, M Du, R Sun, G Phillips Value in Health 25 (7), S358, 2022 | 1 | 2022 |
Bayesian variable selection utilizing posterior probability credible intervals M Du, SL Andersen, TT Perls, P Sebastiani medRxiv, 2021.01. 13.21249759, 2021 | 1 | 2021 |
Numbers Needed to Treat and Costs Per Improved Outcome Among Treatments for Myasthenia Gravis T Hughes, C Qi, J Wang, H Yang, D Gelinas, E Brauer, M Du, R Sun, ... Neurology 99 (23_Supplement_2), S38-S39, 2022 | | 2022 |
EE62 The Societal Burden of Bardet-Biedl Syndrome in the United States U Mallya, C Huber, ML Zichlin, M Du, H Wang, PI Neumann, N Kirson Value in Health 25 (12), S65, 2022 | | 2022 |
Bayesian modeling of neuropsychological test scores M Du Boston University, 2021 | | 2021 |
Early Differences in Cognition Associated With Familial Longevity and ApoE Genotype Using Digital Technology S Andersen, M Du, N Roth, M Wojczynski, B Thyagarajan, T Perls, ... Innovation in Aging 4 (Supplement_1), 656-657, 2020 | | 2020 |